Operating Income (Loss) in USD of HTG MOLECULAR DIAGNOSTICS, INC from Q1 2014 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
HTG MOLECULAR DIAGNOSTICS, INC quarterly/annual Operating Income (Loss) history and change rate from Q1 2014 to Q1 2023.
  • HTG MOLECULAR DIAGNOSTICS, INC Operating Income (Loss) for the quarter ending 31 Mar 2023 was -$5.01M, a 19.9% increase year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC Operating Income (Loss) for the twelve months ending 31 Mar 2023 was -$19.6M, a 0.47% decline year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Operating Income (Loss) for 2022 was -$20.8M, a 16.9% decline from 2021.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Operating Income (Loss) for 2021 was -$17.8M, a 9% increase from 2020.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Operating Income (Loss) for 2020 was -$19.6M, a 3.3% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$19.6M -$5.01M +$1.24M +19.9% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q4 2022 -$20.8M -$4.55M +$379K +7.69% 01 Oct 2022 31 Dec 2022 10-K 30 Mar 2023
Q3 2022 -$21.2M -$4.35M -$118K -2.78% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 -$21.1M -$5.68M -$1.59M -39.1% 01 Apr 2022 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 -$19.5M -$6.25M -$1.67M -36.5% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$17.8M -$4.93M -$907K -22.5% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$16.9M -$4.23M +$941K +18.2% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$17.9M -$4.08M +$918K +18.4% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$18.8M -$4.58M +$810K +15% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$19.6M -$4.02M +$292K +6.76% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 -$19.9M -$5.17M -$551K -11.9% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$19.3M -$5M -$293K -6.23% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$19M -$5.39M -$73.2K -1.38% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$19M -$4.31M -$2.25M -109% 01 Oct 2019 31 Dec 2019 10-K 25 Mar 2021
Q3 2019 -$16.7M -$4.62M +$184K +3.83% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$16.9M -$4.71M -$643K -15.8% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 -$16.3M -$5.32M -$92.8K -1.78% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 -$16.2M -$2.07M -$383K -22.8% 01 Oct 2018 31 Dec 2018 10-K 25 Mar 2020
Q3 2018 -$15.8M -$4.8M +$298K +5.83% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$16.1M -$4.06M +$1.44M +26.2% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019
Q1 2018 -$17.5M -$5.23M +$204K +3.76% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 -$17.7M -$1.68M +$3.56M +67.9% 01 Oct 2017 31 Dec 2017 10-K 07 Mar 2019
Q3 2017 -$21.3M -$5.1M +$957K +15.8% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 -$22.2M -$5.51M +$853K +13.4% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 -$23.1M -$5.43M +$1.24M +18.5% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 -$24.3M -$5.24M +$98.1K +1.84% 01 Oct 2016 31 Dec 2016 10-K 23 Mar 2018
Q3 2016 -$24.4M -$6.06M -$1.23M -25.6% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 -$23.2M -$6.36M -$1.64M -34.7% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017
Q1 2016 -$21.6M -$6.67M -$2.67M -66.7% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$18.9M -$5.34M -$1.96M -57.8% 01 Oct 2015 31 Dec 2015 10-K 23 Mar 2017
Q3 2015 -$16.9M -$4.83M -$1.69M -53.8% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$15.2M -$4.72M -$1.15M -32.1% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 -$14.1M -$4M -$1.25M -45.4% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016
Q4 2014 -$12.8M -$3.39M 01 Oct 2014 31 Dec 2014 10-K 25 Mar 2016
Q3 2014 -$3.14M 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 -$3.58M 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015
Q1 2014 -$2.75M 01 Jan 2014 31 Mar 2014 10-Q 08 Jun 2015

HTG MOLECULAR DIAGNOSTICS, INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$20.8M -$3.01M -16.9% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023
2021 -$17.8M +$1.76M +9% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$19.6M -$626K -3.3% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 -$19M -$2.8M -17.3% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021
2018 -$16.2M +$1.56M +8.82% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2020
2017 -$17.7M +$6.61M +27.2% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019
2016 -$24.3M -$5.44M -28.8% 01 Jan 2016 31 Dec 2016 10-K 23 Mar 2018
2015 -$18.9M -$6.04M -47% 01 Jan 2015 31 Dec 2015 10-K 23 Mar 2017
2014 -$12.8M 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.